Welcome to the Website of the
European Cancer Moonshot Lund Center
Participating in the Largest International Cancer Initiative of All Time
In the US alone, screening of 75,000 patients over 7 years
with a budget of USD 1.8 billion is planned
“A road map to end cancer as we know it”
47th Vice President of the USA, Joe Biden
Our mission is to conduct cancer research that is beneficial for all patients.
Our primary goal is to identify proteins from melanoma tissues that can be used to aid early diagnosis of the disease.
Tissue and blood samples are collected from patients and analyzed by protein sequencing & analysis using state-of-the-art mass spectrometry (MS). Computer analysis of the generated data combined with person-specific information (e.g., age, gender, weight, hours of sun exposure etc.) will enable the discovery of important diagnostic patterns.
US-SWEDEN CANCER SUMMIT, 2024 March 13.
On March 13, 2024, signing ceremony, which occurred at the US-Sweden Cancer Summit in the House of Sweden. This agreement further strengthens our strong bilateral partnership focused on advancing cancer research, prevention, control, and management. Read more. https://lnkd.in/gVY-AwNr
Kimryn Rathmell, M.D., Ph.D., NCI Director Ms. Andrea Palm, HHS Deputy Director Ms. Acko Ankarberg Johansson, Minister for Healthcare, Sweden Catharine Young, Ph.D. Assistant Director, White House Cancer Moonshot Engagement and Policy Urban Ahlin, Ambassador of Sweden
Deputy Secretary for Health and Human Services, Andrea Palm, and Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Joel Apelthun/Government Offices of Sweden
European Cancer Moonshot Center LUND, SWEDEN
Situated at the core of Lund University’s hospital campus, the European Cancer Moonshot Lund Center has, over the last four years, successfully instituted cutting-edge laboratories at the Biomedical Center in Lund. Notably, Lund University ranks 95th among the world’s top 100 universities (2022). The center boasts seamless connectivity to the hospital and patient departments through convenient skywalk connections.
Lund University hospital is an integral part of the southern Swedish healthcare organization, “Region Skåne,” encompassing ten hospitals and overseen by a unified senior management team. This strategic integration ensures a collaborative and cohesive approach to healthcare delivery and research, further strengthening the European Cancer Moonshot Lund Center’s position as a pioneering hub at the intersection of academic excellence, medical innovation, and patient care.
As an ambulance arrives at the Lund hospital, transporting a cancer patient, it enters the realm of the European Cancer Moonshot Center. Nestled within the hospital’s vicinity, this specialized center stands as a dedicated hub for cutting-edge cancer research, prepared to tackle new and intricate scientific challenges.
The integration of the hospital and the European Cancer Moonshot Center signifies a seamless collaboration between medical care and scientific advancement. The facility is poised to address the evolving landscape of cancer, leveraging its state-of-the-art resources and expertise to provide comprehensive care to patients while simultaneously pushing the boundaries of scientific discovery.
With a commitment to advancing the frontiers of cancer research, the European Cancer Moonshot Center becomes a dynamic space where medical practitioners, researchers, and scientists converge. The arrival of a cancer patient symbolizes the continuous cycle of care and research, emphasizing the Center’s pivotal role in translating scientific innovations into tangible improvements in patient outcomes. Together, the hospital and the European Cancer Moonshot Center exemplify a holistic approach to cancer treatment, where scientific exploration and compassionate care intersect to create a transformative impact on the trajectory of cancer patients’ lives.
